We're not just envisioning the future of early disease detection—we're creating it.
Novelna at JPM Week
Novelna will be attending #JPMWeek in San Francisco from January 13–16, 2025. If you’re interested in exploring innovative collaborations, discussing potential partnerships, or learning more about our latest initiatives, we’d love to connect.
You can reach us through the BIO Partnering platform or directly via info@novelna.com
Technology
Our proteomics approach offers significantly higher accuracy than existing tests. Our results are a testament to the effectiveness of our innovative approach.
Platform
Developing effective screening tests is expensive and not feasible for many diseases. Our platform allows us to radically reduce the cost of discovery and validation of novel diagnostics.
Pipelines
Two out of three global cancer deaths occur in cases where there is no effective screening test. At Novelna, we are creating a wide range of diagnostics to address this challenge.